Clincosm LogoSign in Get a demo

B-Cell Non-Hodgkin Lymphoma

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Duarte (Best Practice, Cognitive Intervention, Comprehensive Geriatric

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Best Practice
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 19, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

B-Cell Non-Hodgkin Lymphoma Trial in Seattle (Anakinra)

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Anakinra
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

B-cell Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Mosunetuzumab (SC), Polatuzumab vedotin)

Recruiting
  • B-cell Non-Hodgkin Lymphoma
  • Mosunetuzumab (IV)
  • +4 more
  • Birmingham, Alabama
  • +28 more
Jan 6, 2023

B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 9, 2022

B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma
  • +4 more
  • (no location specified)
Dec 7, 2022

B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Loncastuximab Tesirine
  • +4 more
  • Pembroke Pines, Florida
  • +19 more
Jul 22, 2022

B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

B-Cell Non-Hodgkin Lymphoma Trial in China (Epcoritamab, Cyclophosphamide, Rituximab)

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Beijing, Beijing, China
  • +20 more
May 31, 2022

B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-OX40 Antibody BMS 986178
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
May 3, 2022

Relapsed or Refractory Haematological Malignancies Including, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in

Completed
  • Relapsed or Refractory Haematological Malignancies Including
  • +10 more
  • Aachen, Germany
  • +11 more
Oct 21, 2021

B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 6, 2021

Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Chicago (Pembrolizumab)

Recruiting
  • Classical Hodgkin Lymphoma
  • +3 more
  • Chicago, Illinois
    University of Chicago
Jun 29, 2021

Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +6 more
  • Anti-Thymocyte Globulin
  • +5 more
  • Stanford, California
    Stanford University, School of Medicine
Jun 1, 2021

B-cell Non-Hodgkin Lymphoma Trial in Taipei (Welgenaleucel)

Unknown status
  • B-cell Non-Hodgkin Lymphoma
  • Welgenaleucel
  • Taipei, Taiwan
    Tri-Service General Hospital
Jan 16, 2021

B-cell Non-Hodgkin Lymphoma Trial in Duarte, Minneapolis, Lebanon (DI-Leu16-IL2)

Terminated
Has Results
  • B-cell Non-Hodgkin Lymphoma
  • Duarte, California
  • +2 more
Nov 2, 2020

B-cell Non-Hodgkin Lymphoma Trial in United States (DI-Leu16-IL2)

Terminated
Has Results
  • B-cell Non-Hodgkin Lymphoma
  • Duarte, California
  • +4 more
Nov 2, 2020

Adult DLBCL, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Seattle (Autologous Hematopoietic Stem Cell

Completed
Has Results
  • Adult Diffuse Large B-Cell Lymphoma
  • +5 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Mar 3, 2020

B-cell Non-Hodgkin Lymphoma Trial in Beijing (CD19-directed CAR-T cells)

Completed
  • B-cell Non-Hodgkin Lymphoma
  • CD19-directed CAR-T cells
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 3, 2020

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (Platelet Transfusion)

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +13 more
  • Platelet Transfusion
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2019